Oral R115866 in the treatment of moderate to severe facial acne vulgaris: an exploratory study

Abstract

The current data indicate that treatment with oral R115866 1 mg once daily for 12 weeks in patients with moderate to severe facial acne vulgaris is efficacious and well tolerated and merits further investigation.